Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (28)
Sandeep Kaur, Anila Kumari & Vandana Sharma. 2022. Edible Food Packaging. Edible Food Packaging
433
445
.
Amir Sadra Zangouei, Amir Hossein Barjasteh, Hamid Reza Rahimi, Majid Mojarrad & Meysam Moghbeli. (2020) Role of tyrosine kinases in bladder cancer progression: an overview. Cell Communication and Signaling 18:1.
Crossref
Crossref
Fabrizio Di Maida, Andrea Mari, Cristina Scalici Gesolfo, Antonina Cangemi, Rosalinda Allegro, Simone Sforza, Andrea Cocci, Riccardo Tellini, Lorenzo Masieri, Antonio Russo, Marco Carini, Andrea Minervini & Vincenzo Serretta. (2019) Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression. Clinical Genitourinary Cancer 17:4, pages e751-e758.
Crossref
Crossref
Tadanobu Nagaya, Shuhei Okuyama, Fusa Ogata, Yasuhiro Maruoka, Deborah W. Knapp, Sophia N. Karagiannis, Judit Fazekas-Singer, Peter L. Choyke, Amy K. LeBlanc, Erika Jensen-Jarolim & Hisataka Kobayashi. (2018) Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody. Oncotarget 9:27, pages 19026-19038.
Crossref
Crossref
Regina Mora Vidal, Sergio Regufe da Mota, Annette Hayden, Hannah Markham, James Douglas, Graham Packham & Simon J. Crabb. (2018) Epidermal Growth Factor Receptor Family Inhibition Identifies P38 Mitogen-activated Protein Kinase as a Potential Therapeutic Target in Bladder Cancer. Urology 112, pages 225.e1-225.e7.
Crossref
Crossref
Kiwamu HANAZONO, Shinya FUKUMOTO, Yoshio KAWAMURA, Yoshifumi ENDO, Tsuyoshi KADOSAWA, Hidetomo IWANO & Tsuyoshi UCHIDE. (2015) Epidermal growth factor receptor expression in canine transitional cell carcinoma. Journal of Veterinary Medical Science 77:1, pages 1-6.
Crossref
Crossref
Sounak Gupta & Donna E. Hansel. 2015. Urological Oncology. Urological Oncology
563
590
.
. 2011. Growth Factors and Their Receptors in Cell Differentiation, Cancer and Cancer Therapy. Growth Factors and Their Receptors in Cell Differentiation, Cancer and Cancer Therapy
249
347
.
Yuko Yoshio, Kenichiro Ishii, Shigeki Arase, Yasuhide Hori, Kohei Nishikawa, Norihito Soga, Hideaki Kise, Kiminobu Arima & Yoshiki Sugimura. (2010) Effect of transforming growth factor α overexpression on urogenital organ development in mouse. Differentiation 80:2-3, pages 82-88.
Crossref
Crossref
Hussein M Khaled, Abeer A Bahnassy, Amira A Raafat, Abdel-Rahman N Zekri, Maha S Madboul & Nadia M Mokhtar. (2009) Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer. BMC Cancer 9:1.
Crossref
Crossref
Adrianos Nezos, Nikolaos Pissimisis, Peter Lembessis, Antigone Sourla, Peter Dimopoulos, Theodore Dimopoulos, Kostantinos Tzelepis & Michael Koutsilieris. (2009) Detection of circulating tumor cells in bladder cancer patients. Cancer Treatment Reviews 35:3, pages 272-279.
Crossref
Crossref
Xingya Wang, Jennifer K.L. Colby, Robert C. Rengel, Susan M. Fischer, Steven K. Clinton & Russell D. Klein. (2009) Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes. Molecular Carcinogenesis 48:1, pages 1-13.
Crossref
Crossref
Micah A. Jacobs, Chad Wotkowicz, Egbert D. Baumgart, Brasil Silva Neto, Kimberly M. Rieger-Christ, Trisha Bernier, Michael S. Cohen, John A. Libertino & Ian C. Summerhayes. (2007) Epidermal Growth Factor Receptor Status and the Response of Bladder Carcinoma Cells to Erlotinib. Journal of Urology 178:4, pages 1510-1514.
Crossref
Crossref
Hiroshi Tsuruta, Hiroyuki Kishimoto, Takehiko Sasaki, Yasuo Horie, Miyuki Natsui, Yoshiko Shibata, Koichi Hamada, Nobuyuki Yajima, Koichi Kawahara, Masato Sasaki, Norihiko Tsuchiya, Katsuhiko Enomoto, Tak Wah Mak, Toru Nakano, Tomonori Habuchi & Akira Suzuki. (2006) Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients. Cancer Research 66:17, pages 8389-8396.
Crossref
Crossref
Delphine Amsellem-Ouazana, Ivan Bièche, Vincent Molinié, Caroline Elie, Annick Vieillefond, Sengül Tozlu, Henry Botto, Bernard Debré & Rosette Lidereau. (2006) Is Quantitative Real-Time RT-PCR an Adjunct to Immunohistochemistry for the Evaluation of ErbB2 Status in Transitional Carcinoma of the Bladder?. European Urology 49:6, pages 1035-1043.
Crossref
Crossref
Delphine Amsellem-Ouazana, Ivan Bièche, Sengül Tozlu, Henry Botto, Bernard Debré & Rosette Lidereau. (2006) Gene Expression Profiling of ERBB Receptors and Ligands in Human Transitional Cell Carcinoma of the Bladder. Journal of Urology 175:3, pages 1127-1132.
Crossref
Crossref
E. N. Politi, A. C. Lazaris, S. Lambropoulou, D. Alexopoulou, V. Kyriakidou & H. Koutselini. (2005) Epidermal growth factor receptor and proliferating cell nuclear antigen expression in urine ThinPrep specimens. Cytopathology 16:6, pages 303-308.
Crossref
Crossref
Ranveig Rotterud, Jahn Marthin Nesland, Aasmund Berner & Sophie D. Fossa. (2005) Expression of the epidermal growth factor receptor family in normal and malignant urothelium. BJU International 95:9, pages 1344-1350.
Crossref
Crossref
M. Retz & J. Lehmann. 2005. Blasenkarzinom. Blasenkarzinom
27
65
.
Jose L. Dominguez-Escrig, John D. Kelly, David E. Neal, Sonya M. King & Barry R. Davies. (2004) Evaluation of the Therapeutic Potential of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib in Preclinical Models of Bladder Cancer. Clinical Cancer Research 10:14, pages 4874-4884.
Crossref
Crossref
Aleem Gangjee, Jie Yang, Michael A. Ihnat & Shekhar Kamat. (2003) Antiangiogenic and antitumor agents. Bioorganic & Medicinal Chemistry 11:23, pages 5155-5170.
Crossref
Crossref
Petia P. Simeonova, Shiyi Wang, Tracy Hulderman & Michael I. Luster. (2002) c-Src-dependent Activation of the Epidermal Growth Factor Receptor and Mitogen-activated Protein Kinase Pathway by Arsenic. Journal of Biological Chemistry 277:4, pages 2945-2950.
Crossref
Crossref
I Kausch & A Böhle. (2002) Molecular Aspects of Bladder Cancer. European Urology 41:1, pages 15-29.
Crossref
Crossref
Andreas Böhle, Sven Brandau, Christoph Durek, Peter Ardelt & Ingo Kausch. 2002. Molekularmedizinische Grundlagen von nicht-hereditären Tumorerkrankungen. Molekularmedizinische Grundlagen von nicht-hereditären Tumorerkrankungen
291
328
.
Kamal S. Pohar & Carlos Cordon-Cardo. 2002. Cancer Precursors. Cancer Precursors
344
361
.
Alka Kurup, Rajni Garg & Corwin Hansch. (2001) Comparative QSAR Study of Tyrosine Kinase Inhibitors. Chemical Reviews 101:8, pages 2573-2600.
Crossref
Crossref
Tania Crombet, Olga Torres, Elia Neninger, Mauricio Catalá, Nelson Rodríguez, Mayra Ramos, Eduardo Fernández, Normando Iznaga, Rolando Pérez & Agustin Lage. (2001) Phase I Clinical Evaluation of a Neutralizing Monoclonal Antibody against Epidermal Growth Factor Receptor. Cancer Biotherapy and Radiopharmaceuticals 16:1, pages 93-102.
Crossref
Crossref
Jerome W. KosmederIIII & John M. Pezzuto. 2001. Cancer Chemoprevention. Cancer Chemoprevention
31
61
.